Latest News & Features
Big Pharma
On August 5, Swiss pharmaceutical company Roche signed an agreement with the MPP to increase access to its drug valganciclovir (Valcyte), an oral medicine for the treatment of preventable viral infection cytomegalovirus (CMV). 5 August 2013
Asia
India’s Intellectual Property Appeal Board has revoked a patent covering GlaxoSmithKline’s breast cancer drug Tykerb, in the latest blow to western pharmaceutical companies in India. 2 August 2013
Asia-Pacific
The Intellectual Property Appellate Board in Chennai has cancelled two trademarks associated with versions of Viagra. 2 August 2013
Europe
The Court of Appeal for England and Wales has upheld the Patent Court’s decision that Teva Pharmaceutical Industries’ UK patent 762,888, relating to the multiple sclerosis drug Copaxone, is valid. 1 August 2013
Americas
Gabriel Di Blasi outlines the existing impediments to developing new biotechnology products in Brazil,
and considers recent efforts to improve the situation. 31 July 2013
Europe
At some offices, the passage of a patent through the system is not quite as fast as applicants might hope—and at others it may be quicker than they would like. Matt Smith and Jonathan Wills outline the situation. 31 July 2013
Americas
Danish firm Bavarian Nordic has a portfolio of patents for vaccines and cancer treatments, but likes to keep some of its cards close to its chest, as LSIPR finds out. 31 July 2013
article
A US court has ruled that an Israeli company’s patent for a multiple sclerosis (MS) drug is invalid, paving the way for rivals to market a generic version. 30 July 2013
Americas
A US court has upheld a decision ruling that a continuation patent filed by a bio-tech company is invalid. 26 July 2013
Americas
The chair of the FTC has said it will continue to challenge pay-for-delay court settlements in the pharmaceutical industry and has hailed a Supreme Court ruling as a victory for consumers. 25 July 2013